These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6033895)

  • 21. Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.
    Fraser IS; Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Tsong YY; Sivin I
    Contraception; 2005 Jul; 72(1):40-5. PubMed ID: 15964291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservative management of bilateral massive edema of the ovary. A case report.
    Hubbell GP; Punch MR; Elkins TE; Abrams GD
    J Reprod Med; 1993 Jan; 38(1):61-4. PubMed ID: 8441135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms.
    Jensen JT; Archer DF
    Expert Opin Pharmacother; 2008 Feb; 9(2):319-27. PubMed ID: 18201154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study of a low-dose contraceptive--Femodene].
    Rachev E; Damianov L; Dukovski A; Katsarova M
    Akush Ginekol (Sofiia); 1995; 34(3):71-3. PubMed ID: 8787249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of quinestrol on cervical mucus and sperm penetration in patients with cervical hostility.
    Roland M
    Int J Fertil; 1967; 12(2):251-4. PubMed ID: 6068018
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of estrogen properties of quinestrol in human females.
    Roland M; Clyman MJ; Decker A; Ober WB; Bronstein SB
    Int J Fertil; 1967; 12(2):176-80. PubMed ID: 6033894
    [No Abstract]   [Full Text] [Related]  

  • 27. Postoperative long-term maintenance therapy with oral contraceptives after gonadotropin-releasing hormone analog treatment in women with ovarian endometrioma.
    Park HJ; Koo YA; Yoon BK; Choi D
    J Minim Invasive Gynecol; 2009; 16(1):34-9. PubMed ID: 18976968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
    Archer DF; Jensen JT; Johnson JV; Borisute H; Grubb GS; Constantine GD
    Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A preliminary study on gossypol used in gynecology and its mechanism of action (author's transl)].
    Zhonghua Fu Chan Ke Za Zhi; 1981 Jul; 16(3):132-6. PubMed ID: 7327033
    [No Abstract]   [Full Text] [Related]  

  • 30. [A clinical study of the triphasic contraceptive Tri-Regol].
    Rachev E
    Akush Ginekol (Sofiia); 1995; 34(2):64-5. PubMed ID: 8651433
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical study of low-dose oral contraceptives (with low-doses of ethinyl estradiol), widely used in practice].
    Nalbanski B; Tsekova K; Ivanov S
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():20-3. PubMed ID: 11519317
    [No Abstract]   [Full Text] [Related]  

  • 32. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
    Barbosa IC; Filho CI; Faggion D; Baracat EC
    Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinestrol therapy in functional infertility.
    Cohen MR
    Int J Fertil; 1967; 12(2):255-60. PubMed ID: 6033905
    [No Abstract]   [Full Text] [Related]  

  • 35. [Escapelle - a method of choice for emergency contraception ].
    Tanchev L
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():24-7. PubMed ID: 19496450
    [No Abstract]   [Full Text] [Related]  

  • 36. Biologic effects of various doses of ethinyl estradiol in postmenopausal women.
    Mandel FP; Geola FL; Lu JK; Eggena P; Sambhi MP; Hershman JM; Judd HL
    Obstet Gynecol; 1982 Jun; 59(6):673-9. PubMed ID: 6281707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 38. Lower- vs higher-dose estrogen for contraception.
    Kripke C
    Am Fam Physician; 2005 Oct; 72(7):1224-5. PubMed ID: 16229072
    [No Abstract]   [Full Text] [Related]  

  • 39. Less estrogen in new oral contraceptive.
    Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
    [No Abstract]   [Full Text] [Related]  

  • 40. Dexamethasone suppression test in the management of hyperandrogenized patients.
    Abraham GE; Maroulis GB; Boyers SP; Buster JE; Magyar DM; Elsner CW
    Obstet Gynecol; 1981 Feb; 57(2):158-65. PubMed ID: 6450905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.